Загрузка...
Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model
BACKGROUND: Toxoplasma is an important source of foodborne hospitalization with no safe and effective therapy against chronic or congenital Toxopalsmosis. Atovaquone is a drug of choice but not approved for use in congenital Toxoplasmosis. We hypothesized atovaquone to be safe and effective against...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International Scientific Literature, Inc.
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3560658/ https://ncbi.nlm.nih.gov/pubmed/22936182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.883342 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|